Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much her Department spent on interpreters and related translation services in 2025.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department’s expenditure in this category for calendar year 2025 was £96,452. More than half these costs were incurred by the National Maternity and Neonatal Investigation, as part of the outreach work conducted with families for whom language barriers had affected the care they received, as discussed extensively in Baroness Amos’s final report. Of the remaining expenditure, the large majority was accounted for by the purchase of ‘Easy Read’ English services, Welsh translation services, and British Sign Language services.

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the Medicines and Healthcare products Regulatory Agency was responsible for applying for the creation of a medical dictionary for regulatory activities code for post-SSRI sexual dysfunction in 2021.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

No, but the Medicines and Healthcare products Regulatory Agency did have discussions on the underlying data in this area with officials responsible for the medical dictionary for regulatory activities, which resulted in them adding the lower level term “post-SSRI sexual dysfunction” to the regulatory dictionary under sexual dysfunction.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what analysis she has undertaken of the reasons why trained obstetricians and gynaecologists leave NHS employment before retirement age; and what proportion of those leaving in each of the last five years cited (a) workload, (b) burnout, (c) working hours, (d) geographical location, (e) pay and (f) retirement and flexible retirement.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of doctors completing higher specialty training in obstetrics and gynaecology in each of the last five years remain employed by the NHS five years after completing training.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what additional national incentives are available to NHS trusts to recruit and retain consultant obstetricians and gynaecologists in remote rural and coastal areas; and what assessment she has made of the effectiveness of those incentives.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her department has made of the adequacy of the number of specialist training spaces required to address the low number of Consultant Neurologists in England.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Regarding specialty training places, I refer the Hon. Member to the answer provided on 8 September in response to Question 23516.

Alongside this, NHS England has introduced several measures to improve care for patients with multiple sclerosis (MS), including the Neurology Transformation Programme to support integrated care boards to deliver the right service at the right time for all neurology patients, including those with MS. This programme has developed a national data dashboard for integrated care systems to monitor delivery of MS care, including disease-modifying therapies. NHS England has also developed guidance for systems on improving access to disease-modifying treatments closer to home.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the shortage of Consultant Neurologists on patient access to consistent and timely Multiple Sclerosis care.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Regarding specialty training places, I refer the Hon. Member to the answer provided on 8 September in response to Question 23516.

Alongside this, NHS England has introduced several measures to improve care for patients with multiple sclerosis (MS), including the Neurology Transformation Programme to support integrated care boards to deliver the right service at the right time for all neurology patients, including those with MS. This programme has developed a national data dashboard for integrated care systems to monitor delivery of MS care, including disease-modifying therapies. NHS England has also developed guidance for systems on improving access to disease-modifying treatments closer to home.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many and what proportion of A&E attendances have been diverted to (a) urgent treatment centre, (b) minor injuries unit, (c) primary care, (d) pharmacy, and (e) other service in each of the last 12 months for which figures are available.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The information requested is not collected centrally in this format.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many and what proportion of A&E treatment episodes were at a level that could have been delivered in a (a) urgent treatment centre or (b) minor injuries unit in each of the last 12 months for which figures are available.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The information requested is not collected centrally in this format.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce NHS waiting times for elective procedures.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

As set out in the Plan for Change, we are committed to returning by March 2029 to the National Health Service constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment, ensuring patients get timely access to the procedures they need.

We promised change, and we’ve delivered, with a reduction in the waiting list of over 290,000 since the Government came into office, despite over 44.7 million referrals onto the list in that period.

This progress has been made through setting ambitious targets, investing in modernisation, reforming and simplifying pathways, increasing surgical and diagnostic capacity, and empowering patients with faster and more convenient access to care.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of redundancies among university-employed clinical academics on NHS clinical capacity; how many NHS programmed activities are currently provided by university-employed clinical academics; and what estimate has been made of the potential additional cost to NHS trusts of replacing clinical activity lost as a consequence of reductions in university clinical academic posts.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care works closely with the Department for Education on an on-going basis covering a wide range of matters to ensure the education system is supporting healthcare students, while delivering value for money for taxpayers.

Decisions regarding the Strategic Priorities Grant (SPG) and any potential impact of such decisions on university budgets or staffing are a matter for the Department for Education, who manage the SPG and associated budget.

The Department of Health and Social Care has had no discussions with the Nottingham University Hospitals NHS Trust or the University of Nottingham regarding the Future Nottingham restructuring programme. Decisions about recruitment are a matter for individual employers, who manage this at a local level to ensure they have the staff they need to deliver safe and effective care.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions her Department has had with the Department for Education concerning the withdrawal of Strategic Priorities Grant support for clinical academic pay, and what assessment has been made of whether reductions in university clinical academic posts resulting from financial pressures on higher education could increase NHS workforce expenditure.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care works closely with the Department for Education on an on-going basis covering a wide range of matters to ensure the education system is supporting healthcare students, while delivering value for money for taxpayers.

Decisions regarding the Strategic Priorities Grant (SPG) and any potential impact of such decisions on university budgets or staffing are a matter for the Department for Education, who manage the SPG and associated budget.

The Department of Health and Social Care has had no discussions with the Nottingham University Hospitals NHS Trust or the University of Nottingham regarding the Future Nottingham restructuring programme. Decisions about recruitment are a matter for individual employers, who manage this at a local level to ensure they have the staff they need to deliver safe and effective care.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to improve (a) mental and (b) emotional support for children whose parents have been diagnosed with cancer.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department recognises that a cancer diagnosis can have a significant emotional and mental impact not only on patients but also on their children and wider families.

Children whose parents are diagnosed with cancer can access support through National Health Service cancer services, including advice and support from clinical teams, clinical nurse specialists support, and referral to psychological support services where clinically appropriate. Families can also access support from voluntary and community sector organisations, such as Young Lives vs Cancer and Macmillan Cancer Support, which provide information, practical assistance, and emotional support for children, young people, and families affected by cancer.

We continue to work with NHS England and stakeholders to improve support for people affected by cancer and their families.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to protect NHS emergency care staff from violence and aggression from patients and the public.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answers provided on 15 September in response to Questions 27894 and 27895 and on 19 June in response to Question 3468.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has considered expanding regulation of funeral directors.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the Written Statement HCWS295 made on 1 September, which is available at the following link:

https://questions-statements.parliament.uk/written-statements/detail/2026-09-01/hcws295

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make date of birth a mandatory field when reporting a suspected adverse reaction to the Yellow Card scheme run by the Medicines and Healthcare products Regulatory Agency.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

For medicines and vaccines, the Medicines and Healthcare products Regulatory Agency (MHRA) aligns with internationally recognised pharmacovigilance standards including the International Council for Harmonisation E2B (R3) standard for the collection and transmission of adverse reaction data. While reporters are encouraged to provide as much relevant information as possible, including date of birth where known, a valid individual case safety report is only required to contain sufficient information to identify a patient, such as age group, sex, initials, or a patient medical record number. In general, the MHRA seeks to collect sufficient information to support effective safety monitoring, whilst maintaining a proportionate and accessible system to encourage reporting from healthcare professionals, patients and carers. Requiring information that may not always be immediately available could create an unnecessary barrier to potential reporting rates.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many Fracture Liaison Services are currently operating across the Liverpool City Region; and what steps her Department is taking to improve Fracture Liaison Service provision across the region.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

The Fracture Liaison Service (FLS) database currently has no FLS recorded in the Liverpool City Region, but on the wider issue raised, I refer the Hon. Member to the answer provided on 20 July in response to Question 18686.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will publish a breakdown of the top 10 recorded causes for delayed discharge by total number of bed days lost, using the National Codes set out in the NHS Data Model and Dictionary (a) in England and (b) by NHS trust in each of the last 12 months for which figures are available.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

The data is not held or published in the format requested and could only be collated and verified for the purposes of answering this question at disproportionate cost.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to establish a Fracture Liaison Service in Liverpool; and when she expects people in Liverpool to benefit from such a service.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

The Fracture Liaison Service (FLS) database currently has no FLS recorded in the Liverpool City Region, but on the wider issue raised, I refer the Hon. Member to the answer provided on 20 July in response to Question 18686.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when she plans to respond to the email from the hon. Member for South Shropshire dated 19 May 2026 with case reference SA44124.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Ministers and officials are in regular contact with elected representatives across the country.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential merits of working with local NHS partners to explore the potential for a pilot involving appropriately qualified community-based professionals to support postnatal physical activity and pelvic-health education, with outcomes evaluated to inform future policy.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Perinatal Pelvic Health Services (PPHS) support the prevention, identification, and treatment of pelvic health problems during pregnancy and for at least one year after birth. As of September 2026, PPHS are available in 34 of 36 integrated care board areas, with NHS England working with the remaining areas to achieve full national coverage. NHS England’s service specification sets standards for care, including providing women with information on pelvic health, potential problems, and how to access support during pregnancy and after birth. It also requires specialist-led training for maternity, primary care, and other relevant professionals.

NHS England’s postnatal toolkit promotes early identification and referral for women who need additional support, including access to specialist pelvic health services. The UK Chief Medical Officers’ physical activity guidelines recommend that postnatal women undertake regular physical activity and begin pelvic floor exercises when able, while the routine six to eight week postnatal general practice check provides an opportunity to discuss recovery, pelvic health, and mental health, with referral to specialist services where appropriate. Through the Women’s Health Strategy for England, the Government is also supporting integrated models of care that bring together maternity, gynaecology, primary care, pelvic health, health visiting, and perinatal mental health services to improve long-term outcomes for women.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to integrate postnatal physical health, pelvic health and mental health within its wider preventative approach to women's health.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Perinatal Pelvic Health Services (PPHS) support the prevention, identification, and treatment of pelvic health problems during pregnancy and for at least one year after birth. As of September 2026, PPHS are available in 34 of 36 integrated care board areas, with NHS England working with the remaining areas to achieve full national coverage. NHS England’s service specification sets standards for care, including providing women with information on pelvic health, potential problems, and how to access support during pregnancy and after birth. It also requires specialist-led training for maternity, primary care, and other relevant professionals.

NHS England’s postnatal toolkit promotes early identification and referral for women who need additional support, including access to specialist pelvic health services. The UK Chief Medical Officers’ physical activity guidelines recommend that postnatal women undertake regular physical activity and begin pelvic floor exercises when able, while the routine six to eight week postnatal general practice check provides an opportunity to discuss recovery, pelvic health, and mental health, with referral to specialist services where appropriate. Through the Women’s Health Strategy for England, the Government is also supporting integrated models of care that bring together maternity, gynaecology, primary care, pelvic health, health visiting, and perinatal mental health services to improve long-term outcomes for women.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what budget has been allocated for water fluoridation over the next five years; and if she will provide a breakdown of the amount proposed to be spent on (a) upgrading or replacing existing fluoridation infrastructure, (b) annual revenue costs for operating existing fluoridation schemes, (c) introducing new fluoridation schemes, including the proposed expansion in the North East of England, and (d) feasibility studies for potential future expansion of water fluoridation, including the locations where such studies are being undertaken.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

Further to the answer provided on 16 February in response to Question HL14539, I can confirm that, over the current Spending Review period, £136 million has been earmarked for community water fluoridation, but I am unable at this stage to provide the Hon. Member with the specific requested breakdown of that spending. Further information on feasibility studies is published at the following links:

https://www.find-tender.service.gov.uk/Notice/001947-2026

https://www.find-tender.service.gov.uk/Notice/056982-2026

https://www.find-tender.service.gov.uk/Notice/002996-2026

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps her Department has taken to improve ambulance response times in (a) Nottinghamshire and (b) England.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to answer given on 26 June in response to Question 11592, which details actions taken both nationally and by East Midlands Ambulance Service, which provides ambulance services in Nottinghamshire.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact on NHS trusts’ access to existing analytical tools, insights and operational capabilities delivered through the Federated Data Platform should the current contract with Palantir not be extended.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the published details regarding the NHS Federated Data Platform contract available on the Contract Finder website and explained at the following link:

https://www.england.nhs.uk/digitaltechnology/nhs-federated-data-platform/security-privacy/contract-explainer/

As a general rule, the Government does not respond to hypothetical scenarios regarding existing contractual arrangements.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether her Department has estimated the cost of not extending the current contract with Palantir, including any termination, exit or break clause payments that would become payable if the contract were not renewed.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the published details regarding the NHS Federated Data Platform contract available on the Contract Finder website and explained at the following link:

https://www.england.nhs.uk/digitaltechnology/nhs-federated-data-platform/security-privacy/contract-explainer/

As a general rule, the Government does not respond to hypothetical scenarios regarding existing contractual arrangements.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information her Department holds on the proportion of patients aged 18 to 25 in England prescribed a selective serotonin reuptake inhibitor who received a follow-up review within one week, in line with NICE guideline NG222.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken forward the recommendations of the Commission on Human Medicines. The timetable for the revised patient information leaflet (PIL) is for it to be available electronically from October and for hard copy availability within packs of medicines three to six months later. The patient card will also be available electronically from October and will begin to be available in or on the box of antidepressant medicine within three to six months.

As an interim measure, the MHRA is working with the manufacturers’ trade associations to evaluate the feasibility of earlier access to the hard copy of the card for patients via pharmacies. The ancillary leaflet is being developed with other healthcare system partners and should be available early in 2027.

The MHRA has requested updates to the PILs for all antidepressants involved in the review to be submitted for approval. The PIL updates require review by the MHRA to ensure accuracy of messaging, and it is the aim for electronic versions of the PILs to be made available as soon as practicable in October.

The MHRA logs all Prevention of Future Deaths reports it receives and can confirm that since 2020, four reports concerning the prescribing of antidepressants, or their safety information have been sent to the MHRA. Responses have been issued in each case. The MHRA sought the advice of several independent committees on the reports and the potential need for regulatory action. In response to some of these reports and the feedback from families and patients, the MHRA convened the Expert Working Group on antidepressant risk minimisation, which made several recommendations for the MHRA and wider healthcare system, including updates to clinical guidance and regulatory documents.

The independent Expert Working Group on antidepressant risk minimisation considered all regulatory options for improving awareness of the risk of suicidal thoughts and behaviours, including adding a warning on the box, in addition to updates to the PILs. For many antidepressant medicines, the inclusion of additional information beyond the statutory requirements is limited by space available on the box. The patient card will be available on or in the box and will be detachable and easily portable, and will provide context to safety messaging and signpost patients on where to get help.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what comparative assessment she has made of the effectiveness of (a) on-pack warnings and (b) patient information leaflets in communicating the risk of suicidal behaviour associated with antidepressant medicines; and whether the Commission on Human Medicines Expert Working Group considered on-pack warnings as part of its review.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken forward the recommendations of the Commission on Human Medicines. The timetable for the revised patient information leaflet (PIL) is for it to be available electronically from October and for hard copy availability within packs of medicines three to six months later. The patient card will also be available electronically from October and will begin to be available in or on the box of antidepressant medicine within three to six months.

As an interim measure, the MHRA is working with the manufacturers’ trade associations to evaluate the feasibility of earlier access to the hard copy of the card for patients via pharmacies. The ancillary leaflet is being developed with other healthcare system partners and should be available early in 2027.

The MHRA has requested updates to the PILs for all antidepressants involved in the review to be submitted for approval. The PIL updates require review by the MHRA to ensure accuracy of messaging, and it is the aim for electronic versions of the PILs to be made available as soon as practicable in October.

The MHRA logs all Prevention of Future Deaths reports it receives and can confirm that since 2020, four reports concerning the prescribing of antidepressants, or their safety information have been sent to the MHRA. Responses have been issued in each case. The MHRA sought the advice of several independent committees on the reports and the potential need for regulatory action. In response to some of these reports and the feedback from families and patients, the MHRA convened the Expert Working Group on antidepressant risk minimisation, which made several recommendations for the MHRA and wider healthcare system, including updates to clinical guidance and regulatory documents.

The independent Expert Working Group on antidepressant risk minimisation considered all regulatory options for improving awareness of the risk of suicidal thoughts and behaviours, including adding a warning on the box, in addition to updates to the PILs. For many antidepressant medicines, the inclusion of additional information beyond the statutory requirements is limited by space available on the box. The patient card will be available on or in the box and will be detachable and easily portable, and will provide context to safety messaging and signpost patients on where to get help.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information her Department holds on how many Prevention of Future Deaths reports concerning the prescribing of, or safety information for, antidepressant medicines the Medicines and Healthcare products Regulatory Agency has received since 2020; and in how many cases guidance or product information was subsequently amended.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken forward the recommendations of the Commission on Human Medicines. The timetable for the revised patient information leaflet (PIL) is for it to be available electronically from October and for hard copy availability within packs of medicines three to six months later. The patient card will also be available electronically from October and will begin to be available in or on the box of antidepressant medicine within three to six months.

As an interim measure, the MHRA is working with the manufacturers’ trade associations to evaluate the feasibility of earlier access to the hard copy of the card for patients via pharmacies. The ancillary leaflet is being developed with other healthcare system partners and should be available early in 2027.

The MHRA has requested updates to the PILs for all antidepressants involved in the review to be submitted for approval. The PIL updates require review by the MHRA to ensure accuracy of messaging, and it is the aim for electronic versions of the PILs to be made available as soon as practicable in October.

The MHRA logs all Prevention of Future Deaths reports it receives and can confirm that since 2020, four reports concerning the prescribing of antidepressants, or their safety information have been sent to the MHRA. Responses have been issued in each case. The MHRA sought the advice of several independent committees on the reports and the potential need for regulatory action. In response to some of these reports and the feedback from families and patients, the MHRA convened the Expert Working Group on antidepressant risk minimisation, which made several recommendations for the MHRA and wider healthcare system, including updates to clinical guidance and regulatory documents.

The independent Expert Working Group on antidepressant risk minimisation considered all regulatory options for improving awareness of the risk of suicidal thoughts and behaviours, including adding a warning on the box, in addition to updates to the PILs. For many antidepressant medicines, the inclusion of additional information beyond the statutory requirements is limited by space available on the box. The patient card will be available on or in the box and will be detachable and easily portable, and will provide context to safety messaging and signpost patients on where to get help.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what training and guidance her Department provides to (a) GPs, (b) midwives and (c) other maternity professionals on postnatal pelvic health and supporting women to return safely to physical activity.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Perinatal Pelvic Health Services (PPHS) support the prevention, identification, and treatment of pelvic health problems during pregnancy and for at least one year after birth. As of September 2026, PPHS are available in 34 of 36 integrated care board areas, with NHS England working with the remaining areas to achieve full national coverage. NHS England’s service specification sets standards for care, including providing women with information on pelvic health, potential problems, and how to access support during pregnancy and after birth. It also requires specialist-led training for maternity, primary care, and other relevant professionals.

NHS England’s postnatal toolkit promotes early identification and referral for women who need additional support, including access to specialist pelvic health services. The UK Chief Medical Officers’ physical activity guidelines recommend that postnatal women undertake regular physical activity and begin pelvic floor exercises when able, while the routine six to eight week postnatal general practice check provides an opportunity to discuss recovery, pelvic health, and mental health, with referral to specialist services where appropriate. Through the Women’s Health Strategy for England, the Government is also supporting integrated models of care that bring together maternity, gynaecology, primary care, pelvic health, health visiting, and perinatal mental health services to improve long-term outcomes for women.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that women receive consistent, evidence-based advice on (a) physical activity, (b) physical recovery and (c) returning safely to exercise as part of postnatal care.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Perinatal Pelvic Health Services (PPHS) support the prevention, identification, and treatment of pelvic health problems during pregnancy and for at least one year after birth. As of September 2026, PPHS are available in 34 of 36 integrated care board areas, with NHS England working with the remaining areas to achieve full national coverage. NHS England’s service specification sets standards for care, including providing women with information on pelvic health, potential problems, and how to access support during pregnancy and after birth. It also requires specialist-led training for maternity, primary care, and other relevant professionals.

NHS England’s postnatal toolkit promotes early identification and referral for women who need additional support, including access to specialist pelvic health services. The UK Chief Medical Officers’ physical activity guidelines recommend that postnatal women undertake regular physical activity and begin pelvic floor exercises when able, while the routine six to eight week postnatal general practice check provides an opportunity to discuss recovery, pelvic health, and mental health, with referral to specialist services where appropriate. Through the Women’s Health Strategy for England, the Government is also supporting integrated models of care that bring together maternity, gynaecology, primary care, pelvic health, health visiting, and perinatal mental health services to improve long-term outcomes for women.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that (a) women are routinely asked about pelvic health during pregnancy and after childbirth and (b) that those experiencing problems are aware of the support available to them.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Perinatal Pelvic Health Services (PPHS) support the prevention, identification, and treatment of pelvic health problems during pregnancy and for at least one year after birth. As of September 2026, PPHS are available in 34 of 36 integrated care board areas, with NHS England working with the remaining areas to achieve full national coverage. NHS England’s service specification sets standards for care, including providing women with information on pelvic health, potential problems, and how to access support during pregnancy and after birth. It also requires specialist-led training for maternity, primary care, and other relevant professionals.

NHS England’s postnatal toolkit promotes early identification and referral for women who need additional support, including access to specialist pelvic health services. The UK Chief Medical Officers’ physical activity guidelines recommend that postnatal women undertake regular physical activity and begin pelvic floor exercises when able, while the routine six to eight week postnatal general practice check provides an opportunity to discuss recovery, pelvic health, and mental health, with referral to specialist services where appropriate. Through the Women’s Health Strategy for England, the Government is also supporting integrated models of care that bring together maternity, gynaecology, primary care, pelvic health, health visiting, and perinatal mental health services to improve long-term outcomes for women.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to secure access to omaveloxolone for those affected by Friedreich’s ataxia.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answer provided on 29 June in response to Question 11724.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce health inequalities in (a) liver disease and (b) liver cancer outcomes.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answer provided on 20 July in response to Question 17759.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of extending free prescriptions to 16, 17 and 18-year-olds completing an apprenticeship.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

No such assessment has been made but we keep all aspects of prescription charging policy under regular review.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her department has made of the implications for her Department's policies of the recommendations and workforce requirements identified by the Royal College of Obstetricians and Gynaecologists’ Workforce Planning Tool for Obstetrics and Anaesthesia; and whether she plans to implement that tool nationally.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the number of additional obstetricians and gynaecologists required in England to provide safe and sustainable 24-hour maternity services; and what proportion of those additional staff are required in rural and coastal areas.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, further to her Department's Impact Assessment on ICBs as strategic commissioners, published on 14 May 2026, what specific mechanisms will be used to provide enhanced oversight of Integrated Care Board specialised commissioning to monitor compliance with national standards and service specifications.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I have nothing to add at this time to the answer that I gave the Hon. Member on 8 September to Question 25186, but when there are further details to provide, I will ensure that he and other Hon. Members are updated in the usual way.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 8 September 2026 to question 25186, when the regulations determining which specialised services will be commissioned by the Secretary of State and which by Integrated Care Boards will be published; and whether these regulations will be subject to public consultation.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I have nothing to add at this time to the answer that I gave the Hon. Member on 8 September to Question 25186, but when there are further details to provide, I will ensure that he and other Hon. Members are updated in the usual way.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the future responsibilities and functions of the seven Offices for Pan-ICB Commissioning will be in supporting Integrated Care Boards to commission specialised services; and when detailed guidance on this will be published.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I have nothing to add at this time to the answer that I gave the Hon. Member on 8 September to Question 25186, but when there are further details to provide, I will ensure that he and other Hon. Members are updated in the usual way.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans she has to improve the collection and publication of patient outcomes data for specialised services, including through the use of patient-reported outcome measures.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I have nothing to add at this time to the answer that I gave the Hon. Member on 8 September to Question 25186, but when there are further details to provide, I will ensure that he and other Hon. Members are updated in the usual way.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what payment schedule is set out in the Federated Data Platform contract with Palantir; what contractual milestones, deliverables or performance criteria trigger payments; and what proportion of the total contract value has been paid to date against each such milestone.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the published details regarding the NHS Federated Data Platform contract available on the Contract Finder website and explained at the following link:

https://www.england.nhs.uk/digitaltechnology/nhs-federated-data-platform/security-privacy/contract-explainer/

As a general rule, the Government does not respond to hypothetical scenarios regarding existing contractual arrangements.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what arrangements are in place to ensure continuity of service and the transfer of knowledge, systems and operational capability to an alternative supplier if the Palantir contract is terminated or not extended.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the published details regarding the NHS Federated Data Platform contract available on the Contract Finder website and explained at the following link:

https://www.england.nhs.uk/digitaltechnology/nhs-federated-data-platform/security-privacy/contract-explainer/

As a general rule, the Government does not respond to hypothetical scenarios regarding existing contractual arrangements.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that revised patient information leaflet wording on the risk of suicidal behaviour is implemented simultaneously across all 28 antidepressant medicines included in the Commission on Human Medicines review, rather than as each marketing authorisation holder updates its product information.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken forward the recommendations of the Commission on Human Medicines. The timetable for the revised patient information leaflet (PIL) is for it to be available electronically from October and for hard copy availability within packs of medicines three to six months later. The patient card will also be available electronically from October and will begin to be available in or on the box of antidepressant medicine within three to six months.

As an interim measure, the MHRA is working with the manufacturers’ trade associations to evaluate the feasibility of earlier access to the hard copy of the card for patients via pharmacies. The ancillary leaflet is being developed with other healthcare system partners and should be available early in 2027.

The MHRA has requested updates to the PILs for all antidepressants involved in the review to be submitted for approval. The PIL updates require review by the MHRA to ensure accuracy of messaging, and it is the aim for electronic versions of the PILs to be made available as soon as practicable in October.

The MHRA logs all Prevention of Future Deaths reports it receives and can confirm that since 2020, four reports concerning the prescribing of antidepressants, or their safety information have been sent to the MHRA. Responses have been issued in each case. The MHRA sought the advice of several independent committees on the reports and the potential need for regulatory action. In response to some of these reports and the feedback from families and patients, the MHRA convened the Expert Working Group on antidepressant risk minimisation, which made several recommendations for the MHRA and wider healthcare system, including updates to clinical guidance and regulatory documents.

The independent Expert Working Group on antidepressant risk minimisation considered all regulatory options for improving awareness of the risk of suicidal thoughts and behaviours, including adding a warning on the box, in addition to updates to the PILs. For many antidepressant medicines, the inclusion of additional information beyond the statutory requirements is limited by space available on the box. The patient card will be available on or in the box and will be detachable and easily portable, and will provide context to safety messaging and signpost patients on where to get help.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the statement by the Medicines and Healthcare products Regulatory Agency of 1 December 2025 on the conclusions of the Commission on Human Medicines Expert Working Group on antidepressants, what the expected timetable is for (a) the revised patient information leaflet wording, (b) the patient card and (c) the ancillary leaflet to be made available to patients.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken forward the recommendations of the Commission on Human Medicines. The timetable for the revised patient information leaflet (PIL) is for it to be available electronically from October and for hard copy availability within packs of medicines three to six months later. The patient card will also be available electronically from October and will begin to be available in or on the box of antidepressant medicine within three to six months.

As an interim measure, the MHRA is working with the manufacturers’ trade associations to evaluate the feasibility of earlier access to the hard copy of the card for patients via pharmacies. The ancillary leaflet is being developed with other healthcare system partners and should be available early in 2027.

The MHRA has requested updates to the PILs for all antidepressants involved in the review to be submitted for approval. The PIL updates require review by the MHRA to ensure accuracy of messaging, and it is the aim for electronic versions of the PILs to be made available as soon as practicable in October.

The MHRA logs all Prevention of Future Deaths reports it receives and can confirm that since 2020, four reports concerning the prescribing of antidepressants, or their safety information have been sent to the MHRA. Responses have been issued in each case. The MHRA sought the advice of several independent committees on the reports and the potential need for regulatory action. In response to some of these reports and the feedback from families and patients, the MHRA convened the Expert Working Group on antidepressant risk minimisation, which made several recommendations for the MHRA and wider healthcare system, including updates to clinical guidance and regulatory documents.

The independent Expert Working Group on antidepressant risk minimisation considered all regulatory options for improving awareness of the risk of suicidal thoughts and behaviours, including adding a warning on the box, in addition to updates to the PILs. For many antidepressant medicines, the inclusion of additional information beyond the statutory requirements is limited by space available on the box. The patient card will be available on or in the box and will be detachable and easily portable, and will provide context to safety messaging and signpost patients on where to get help.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the average percentage attendance rate was of assigned HRA staff at 3 Piccadilly Place, Manchester in the most recent working week for which figures are available as a percentage of assigned staff attending the workplace and in absolute terms.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

In the most recent working week for which figures are available, the average attendance rate for Health Research Authority staff working at 3 Piccadilly Place, Manchester was 50%, with sixteen staff on average in attendance.

On the wider issues raised, I refer the Hon. Member to the answer provided on 15 September 2025 in response to Question 72016.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment she has made of trends in the percentage of total accident and emergency attendances admitted, transferred, or discharged within four hours for the NHS Birmingham and Solihull Integrated Care Board.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

In August 2026, 71.2% of accident and emergency (A&E) attendances in the NHS Birmingham and Solihull Integrated Care Board were admitted, transferred, or discharged within four hours compared with 73.6% in August 2025. Over the last 12 months, performance has ranged from 70.4% in January 2026, to 74.2% in October 2025.

NHS England publishes monthly accident and emergency performance data, including four-hour performance at system level, at the following link:

https://www.england.nhs.uk/statistics/statistical-work-areas/ae-waiting-times-and-activity/ae-attendances-and-emergency-admissions-2026-27

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to prioritise access to specialist treatment for rare cancers; how patients with lymphoma are being prioritised; and what progress she has made on meeting commitments in those areas.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon. Member to the respective answers provided on 18 September and 21 September in response to Questions 27027 and 27283.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the difference in (a) vacancy rates, (b) time taken to recruit, (c) staff turnover and (d) locum expenditure for consultant obstetrician and gynaecologist posts between rural and urban NHS trusts in England.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether her Department plans to establish a national system for recording temporary suspensions, diversions or closures of maternity and intrapartum services arising from staffing shortages.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether her Department plans to require NHS trusts to report the number of unfilled obstetric and gynaecology rota shifts centrally to NHS England.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 14 September in response to Question 26765.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 8 September 2026 to WPQ 26651, when she expects to publish the findings of the external evaluation of Advice and Guidance and Single Point of Access processes.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Strategy Unit has been commissioned to undertake the evaluation of Advice and Guidance and Single Point of Access processes. Further details will be set out in due course, and more information on the unit’s work is available at the following link:

https://www.strategyunitwm.nhs.uk/

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 8 September 2026 to WPQ 26651, who her Department has commissioned to complete the external evaluation of Advice and Guidance and Single Point of Access processes.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Strategy Unit has been commissioned to undertake the evaluation of Advice and Guidance and Single Point of Access processes. Further details will be set out in due course, and more information on the unit’s work is available at the following link:

https://www.strategyunitwm.nhs.uk/

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether her Department has discussed with Nottingham University Hospitals NHS Trust and the University of Nottingham the potential effect of the Future Nottingham restructuring programme on the number of clinical academic staff providing NHS services and on the clinical capacity available to the Trust.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care works closely with the Department for Education on an on-going basis covering a wide range of matters to ensure the education system is supporting healthcare students, while delivering value for money for taxpayers.

Decisions regarding the Strategic Priorities Grant (SPG) and any potential impact of such decisions on university budgets or staffing are a matter for the Department for Education, who manage the SPG and associated budget.

The Department of Health and Social Care has had no discussions with the Nottingham University Hospitals NHS Trust or the University of Nottingham regarding the Future Nottingham restructuring programme. Decisions about recruitment are a matter for individual employers, who manage this at a local level to ensure they have the staff they need to deliver safe and effective care.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his department will take to safeguard patient data and ensure appropriate use of and access to patient information within any proposed Single Patient Record system.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answer provided in the House of Lords on 13 July in response to Question HL1530.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to improve post-diagnosis support and ongoing care for people diagnosed with Alzheimer's disease or dementia.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the D100: Pathway Assessment Tool, which is available at the following link:

https://www.rcpsych.ac.uk/improving-care/nccmh/service-design-and-development/dementia-100-pathway-assessment-tool

This self-assessment tool has been mapped to the key themes of the Well Pathway for Dementia, Preventing Well, Diagnosing Well, Supporting Well, Living Well, and Dying Well. Under Diagnosing Well, this tool recommends that people with a dementia diagnosis have had their care and support plan reviewed in the preceding 12 months.

We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. We aim to publish the full modern service framework by the end of this calendar year, as recommended by Baroness Casey.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many of the suspected adverse reaction reports of unknown age for the COVID-19 Vaccine Moderna monovalent were followed up by the Medicines and Healthcare products Regulatory Agency to try and recover the missing information.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The requested information is not held centrally by the Department and could only be collated and verified at disproportionate cost.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the adequacy of availability and accessibility of perinatal pelvic health services across England, and what further steps is it taking to ensure women can access timely specialist support when they need it.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Perinatal Pelvic Health Services (PPHS) support the prevention, identification, and treatment of pelvic health problems during pregnancy and for at least one year after birth. As of September 2026, PPHS are available in 34 of 36 integrated care board areas, with NHS England working with the remaining areas to achieve full national coverage. NHS England’s service specification sets standards for care, including providing women with information on pelvic health, potential problems, and how to access support during pregnancy and after birth. It also requires specialist-led training for maternity, primary care, and other relevant professionals.

NHS England’s postnatal toolkit promotes early identification and referral for women who need additional support, including access to specialist pelvic health services. The UK Chief Medical Officers’ physical activity guidelines recommend that postnatal women undertake regular physical activity and begin pelvic floor exercises when able, while the routine six to eight week postnatal general practice check provides an opportunity to discuss recovery, pelvic health, and mental health, with referral to specialist services where appropriate. Through the Women’s Health Strategy for England, the Government is also supporting integrated models of care that bring together maternity, gynaecology, primary care, pelvic health, health visiting, and perinatal mental health services to improve long-term outcomes for women.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the completeness and consistency of data recorded on people diagnosed with secondary breast cancer across NHS Trusts in England, in the context of the latest findings of the National Audit of Metastatic Breast Cancer (NAoMe) published on 10th September.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

Via the National Disease Registration Service (NDRS), NHS England collects, curates, quality assures, and analyses data about people with cancer across the whole of England.

The NDRS data improvement team is working with National Health Service trusts to provide support and guidance to improve their reporting of non-primary cancers, focused on the specific recurrence and progression data fields included in the Cancer Outcomes and Services Dataset. This includes updates on trust submitted recurrence data in our routine ‘diagnoses by provider’ dashboard, available on our NHS facing, secure data quality and insights hub.

The National Cancer Plan for England, published in February this year, committed to define and count recurrent cancers, starting with breast cancer. The NDRS is working towards publishing a baseline figure of metastatic breast cancer patients in the last quarter of 2026 as per the commitment in the plan.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, for (a) brain cancer, (b) breast cancer, (c) lung cancer, (d) bowel cancer and (e) prostate cancer research since 2018, what amount and what percentage of reported public research expenditure consisted of infrastructure, programme or other expenditure not directly attributable to a named research project or study; and by what methodology that expenditure was included within disease-specific research expenditure figures.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The information requested is not available as it is not held centrally. For brain cancer expenditure, I refer the Hon. Member to the answer provided on 25 June in response to Question 9944.

On the wider issues raised, I refer the Hon. Member to the National Cancer Plan, published in February, which sets out the Government’s approach to research and treatment in these and other areas. The plan is available at the following link:

https://www.gov.uk/government/publications/national-cancer-plan-for-england

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Royal College of Emergency Medicine survey data published in its Safe to Care campaign report, 7 September 2026, what steps her Department is taking to reduce hospital overcrowding and corridor care to help prevent staff abuse.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer I gave on 16 July to Question 17438, which sets out the Government’s approach to reducing pressures across urgent and emergency care, including overcrowding and corridor care. NHS England also provides targeted support to trusts experiencing the highest levels of corridor care, including patient flow and reducing overcrowding.

The NHS Staff Standards introduced in July 2026 include a specific standard on violence prevention and reduction. This requires National Health Service organisations to take action to prevent and reduce violence and abuse towards staff, including through risk assessment, training, reporting arrangements, and support for staff following incidents.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 8 September 2026 to WPQ 26651, on what date the external evaluation of Advice and Guidance and Single Point of Access processes (a) was commissioned and (b) will report back.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Strategy Unit has been commissioned to undertake the evaluation of Advice and Guidance and Single Point of Access processes. Further details will be set out in due course, and more information on the unit’s work is available at the following link:

https://www.strategyunitwm.nhs.uk/

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 8 September 2026 to WPQ 26651, what the terms of reference are for the external evaluation of Advice and Guidance and Single Point of Access processes.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Strategy Unit has been commissioned to undertake the evaluation of Advice and Guidance and Single Point of Access processes. Further details will be set out in due course, and more information on the unit’s work is available at the following link:

https://www.strategyunitwm.nhs.uk/

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of employment prospects of newly qualified Physician Associates; and what steps she is taking to ensure that graduates are able to secure appropriate employment following completion of their training.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Further to the answer of 8 June in response to Question 6637, we stress again that physician associates have important roles to play in our health service, and Professor Leng's review represented a welcome opportunity, in her own words, to reset the debate around those roles and enable all staff groups to work collaboratively in future. However, individual decisions on employment remain a matter for local National Health Service employers, based on their assessment of needs in their area.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether it remains the Government's policy that all (a) specialised services and (b) highly specialised services currently commissioned centrally by NHS England will continue to be commissioned nationally by the Secretary of State following the abolition of NHS England; and whether there will be any reduction in the scope of services commissioned centrally.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer provided on 8 September in response to Question 25186.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential implications for her Department's policies on NHS staff retention of findings by the Royal College of Emergency Medicine in its report entitled Safe to Care, published on 7 September 2026, showing that 73 per cent of A&E staff experience or witness violence or aggression on a daily or weekly basis.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answers provided on 15 September in response to Questions 27894 and 27895 and on 19 June in response to Question 3468.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help tackle discrimination against emergency care workers.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answers provided on 15 September in response to Questions 27894 and 27895 and on 19 June in response to Question 3468.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans her Department has to increase the number of dentists in a) Torbay and b) the South West.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answer given on 18 March in response to Question 117934.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans her Department has to increase the number of undergraduate dentistry places.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answer given on 18 March in response to Question 117934.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what is the standard framework for follow-up appointments following a dementia diagnosis and at what intervals healthcare providers are expected to make contact with patients to monitor their wellbeing.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the D100: Pathway Assessment Tool, which is available at the following link:

https://www.rcpsych.ac.uk/improving-care/nccmh/service-design-and-development/dementia-100-pathway-assessment-tool

This self-assessment tool has been mapped to the key themes of the Well Pathway for Dementia, Preventing Well, Diagnosing Well, Supporting Well, Living Well, and Dying Well. Under Diagnosing Well, this tool recommends that people with a dementia diagnosis have had their care and support plan reviewed in the preceding 12 months.

We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. We aim to publish the full modern service framework by the end of this calendar year, as recommended by Baroness Casey.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the current level of out-of-hours dental care provision in South Shropshire.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

No assessment has been made by the Department.

Responsibility for commissioning National Health Service dental services, including urgent and out-of-hours dental care, sits with integrated care boards (ICBs). For the South Shropshire constituency, this is the Shropshire, Telford, and Wrekin ICB. Further information on the ICB’s urgent dental care services can be found at the following link:

https://www.shropshiretelfordandwrekin.nhs.uk/your-health/where-to-get-advice-and-help/dentists/

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the lack of NHS access to omaveloxolone following the termination of the NICE appraisal on patients with Friedreich's ataxia.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Hon Member is right to point out that the company in question withdrew its evidence submission to the National Institute for Health and Care Excellence (NICE), meaning that NICE was unable to complete its appraisal of omaveloxolone. All the potential discussions that the Hon Member asks about are therefore contingent on the company making a new evidence submission.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions her Department has had with the Northern Ireland Department of Health regarding access to omaveloxolone for patients with Friedreich's ataxia in Northern Ireland.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Hon Member is right to point out that the company in question withdrew its evidence submission to the National Institute for Health and Care Excellence (NICE), meaning that NICE was unable to complete its appraisal of omaveloxolone. All the potential discussions that the Hon Member asks about are therefore contingent on the company making a new evidence submission.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions her Department has had with Biogen regarding the company's withdrawal of its evidence submission to NICE for the appraisal of omaveloxolone for the treatment of Friedreich's ataxia.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Hon Member is right to point out that the company in question withdrew its evidence submission to the National Institute for Health and Care Excellence (NICE), meaning that NICE was unable to complete its appraisal of omaveloxolone. All the potential discussions that the Hon Member asks about are therefore contingent on the company making a new evidence submission.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the average percentage attendance rate was of assigned DHSC staff at 3 Piccadilly Place, Manchester in the most recent working week for which figures are available as a percentage of assigned staff attending the workplace and in absolute terms.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

In the most recent working week for which figures are available, the average attendance rate for Health Research Authority staff working at 3 Piccadilly Place, Manchester was 50%, with sixteen staff on average in attendance.

On the wider issues raised, I refer the Hon. Member to the answer provided on 15 September 2025 in response to Question 72016.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the expected timetable is for both commencing and completing the delayed work relating to specialised commissioning arrangements for severe and very severe ME/CFS following the abolition of NHS England.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answers provided on 29 April in response to Question 124134, on 8 June in response to Question HL54, on 3 July in response to Question 12659, and on 6 July in response to Question 13299.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the Department intends to publish any documentation relating to their decision to delay work on specialised commissioning arrangements for severe and very severe ME/CFS.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answers provided on 29 April in response to Question 124134, on 8 June in response to Question HL54, on 3 July in response to Question 12659, and on 6 July in response to Question 13299.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the £4.75m contribution from the Office of Life Sciences for phase two of the Sequence ME & Long Covid study will be supplemented by funding from NIHR.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answers provided on 29 April in response to Question 124134, on 8 June in response to Question HL54, on 3 July in response to Question 12659, and on 6 July in response to Question 13299.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether an equality impact assessment has been undertaken regarding the delay to work on specialised commissioning arrangements for severe and very severe ME/CFS.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answers provided on 29 April in response to Question 124134, on 8 June in response to Question HL54, on 3 July in response to Question 12659, and on 6 July in response to Question 13299.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of General Optical Council guidance on ensuring high street opticians offer patients all clinically appropriate lens options, including short distance varifocals.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The choice of lens supplied to a patient is a matter for the optical professional and patient, taking account of the individual's clinical needs and preferences. General Optical Council standards require optical professionals to recommend appliances that are clinically justified, in the patient’s best interest, and to provide patients with information about all the relevant options in a way they can understand, to support informed decision making.

Patients who are assessed as requiring cataract surgery should be referred in accordance with relevant clinical pathways and local commissioning arrangements. The National Institute for Health and Care Excellence cataract guideline, reference code NG77, is clear that access to cataract surgery should be based on clinical need and the impact of cataracts on a person's daily life. The guideline can be found at the following link:

https://www.nice.org.uk/guidance/ng77

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure commercial eye care providers refer patients for NHS cataract surgery without delay.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The choice of lens supplied to a patient is a matter for the optical professional and patient, taking account of the individual's clinical needs and preferences. General Optical Council standards require optical professionals to recommend appliances that are clinically justified, in the patient’s best interest, and to provide patients with information about all the relevant options in a way they can understand, to support informed decision making.

Patients who are assessed as requiring cataract surgery should be referred in accordance with relevant clinical pathways and local commissioning arrangements. The National Institute for Health and Care Excellence cataract guideline, reference code NG77, is clear that access to cataract surgery should be based on clinical need and the impact of cataracts on a person's daily life. The guideline can be found at the following link:

https://www.nice.org.uk/guidance/ng77

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what is her latest estimate of the cost of a) increasing the upper capital limit for social care to £100,000 and b) increasing the lower capital limit for social care to £25,000.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

On 29 July, as set out in the link below, the Prime Minister set out his objectives to reform the social care system, and brought forward the timetable for Baroness Casey’s commission to inform that reform programme:

https://www.gov.uk/government/news/pm-sets-out-new-path-to-fix-social-care-together-29-july-2026

All aspects of the current system will be reviewed as part of that process, including capital limit thresholds, and we will continue to update Parliament on a regular basis.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to allow patients who are entitled to free NHS prescriptions to voluntarily choose to pay for their prescription.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

People who are entitled to free National Health Service prescriptions can generally choose not to claim their exemption and pay the prescription charge instead, if they wish to do so.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has considered the potential merits of a dedicated scheme to guarantee NHS dental check-ups for children.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government’s 10-Year Health Plan confirmed that child dental health is a priority, and we are committed to delivering fundamental reform of the dental contract before the end of this Parliament to increase dental access and appointments for children and other National Health Service patients. In the meantime, we have introduced other changes to benefit child dental health, as set out in the answer of 18 June in response to Question 9627.

The latest NHS Dental Statistics show continued improvement across a range of key measures, with more NHS dental care being delivered, more dentists providing NHS services, improved access for patients including children which exceeds pre-pandemic levels, increased preventative care for children, and record levels of urgent dental activity. The latest annual dental statistics can be found at the following link:

https://www.nhsbsa.nhs.uk/statistical-collections/dental-england/dental-statistics-england-202526

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what specialist NHS treatment is available for individuals who engage in stalking and fixated behaviour, including through services such as the National Stalking Clinic; and what assessment her Department has made of the adequacy of that provision to meet demand.

Answered by Alison McGovern - Minister of State (Department of Health and Social Care)

Services for individuals who engage in stalking and fixated behaviour are locally commissioned by the National Health Service and multi-agency criminal justice and health partnerships. Treatment through mainstream NHS mental health services is based on an individual’s assessed clinical needs, and stalking behaviour is not, in itself, a mental health condition.

The National Stalking Clinic is provided by the North London NHS Foundation Trust and offers assessment and consultation for adults with complex presentations, primarily following referrals from health, probation, and prison services.

Found: Parliamentary Under-Secretary of State for Women's Health and Maternity re Strategic partnership between DHSC

Found: Including how his responsibilities and engagement will operate across DHSC and BIST, and whether it

Found: Correspondence with Secretary of State, DHSC re.

Found: The Department for Education and Department of Health and Social Care should explain how these children

Found: (DHSC) and the UK Health Security Agency (UKHSA).15 This also comes at a time of upheaval

Found: Although this is not a DHSC debate, it is a chance to shine some light on the progress that has been

Found: (DHSC) and the National Institute for Health and Care Excellence (NICE) on TB drug

Found: 2026_Accessible__1_.pdf 10 https://assets.publishing.service.gov.uk/media/69c3c48b93cc6e8b87a6f614/dhsc-pandemic-preparedness-strategy.pdf

Found: The ODA budget held by the Department of Health and Social Care, which funds global health research

Found: The FCDO and DHSC also report monthly to the international aid transparency initiative (IATI), information

Found: There needs to be good collaboration between FCDO, DHSC and UKHSA.

Found: My NIHR professorship, funded by UK ODA through the Department of Health and Social Care, is what has

Found: Funded by the Department of Health and Social Care's (DHSC) Fleming Fund, CwPAMS supported 50 health

Found: go forward as funding ceased due to the reduction in the UK Department of Health & Social Care’s (DHSC

Found: combines academic and clinical partnerships, - Encourage and support policy work with direct input from DHSC

Found: Correspondence with the Department of Health and Social Care Letter from the Chair to Stephen Kinnock

Found: DHSC and NHSE Response to Childhood Vaccinations Committee Follow-Up Questions (29 July 2026) Scrutiny

Found: UKHSA are leading a group which has brought together experts from DHSC, NHSE (Clinical, Workforce, Public

Question to the Ministry of Justice:

To ask the Secretary of State for Justice, what recent assessment he has made of the potential impact of the Sentencing Act 2026 on the healthcare treatment of offenders who commit minor crimes.

Answered by Catherine McKinnell - Minister of State (Ministry of Justice)

The Sentencing Act 2026 will reduce the use of short custodial sentences and expand the use of community-based disposals where appropriate. This creates opportunities to strengthen routes into treatment pathways, including diverting people with mental health, drug and alcohol needs away from the criminal justice system where appropriate.

The Ministry of Justice is working closely with NHS England and the Department for Health and Social Care (DHSC), who are responsible for healthcare services in the community, to maximise the impact of the available treatment offer, targeting support where it can have the greatest impact.

Liaison and Diversion services play a vital role ensuring that when people first encounter the justice system, they can be referred into appropriate health or social care pathways to ensure they receive the right support from the first point of contact. In parallel, we are working closely with health partners to increase the use and effectiveness of Community Sentence Treatment Requirements, tackling the root causes of offending behaviour through structured treatment.

We are also launching an additional seven Intensive Supervision Courts (ISCs), which provide an alternative to short custodial sentences by keeping eligible offenders in the community with wraparound support, including drug and alcohol treatment, mental health support and judicial oversight.

Question to the Department for Education:

To ask the Secretary of State for Education, what steps she is taking to improve educational support and outcomes for children and young people with acquired brain injury.

Answered by Georgia Gould - Minister of State (Education)

Children with an acquired brain injury can be affected in different ways. Some brain injuries will result in a special educational need or a medical need, whilst others may affect a child in other ways. In whatever way a brain injury manifests, it is essential that the pupil’s individual needs are identified and supported appropriately. Identification and diagnosis of acquired brain injuries are the responsibility of healthcare professionals.

Through the department’s reform of the special educational needs and disabilities (SEND) programme, we have proposed the introduction of National Inclusion Standards. This will support education settings to identify and respond to needs earlier and more consistently, drawing on a broad range of evidence and professional expertise, so that all children and young people can receive the support they need to achieve and thrive.

The National Inclusion Standards will be underpinned by a £200 million training package to ensure that all teachers, educators, teaching assistants, support staff and leaders across early years, schools and post-16 settings can be trained to support pupils with SEND, and a new investment of £3.7 billion to drive more inclusive school estates and create additional specialist places.

In addition, the Department of Health and Social Care is currently developing an Acquired Brain Injury Strategy.

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what assessment he has made of the effectiveness of cross-government working between the Disability Policy Unit, the Department of Health and Social Care and other relevant departments in improving outcomes for disabled people and people with long-term health conditions.

Answered by Stephen Timms - Minister of State (Ministry of Housing Communities and Local Government) (Equalities)

In December 2024, a Lead Minister for Disability was appointed in every government department, including the Department of Health and Social Care, to represent the interests of disabled people and champion disability inclusion and accessibility across their department, as they drive forward progress on the government’s manifesto commitments. The Lead Ministers for Disability have met regularly as a group to discuss improving outcomes for disabled people and people with long-term health conditions.

The Health and Growth Accelerators programme has been established to test the effectiveness of health interventions across three systems- South Yorkshire, West Yorkshire, and North East and North Cumbria- in supporting people back to work or keeping them in work. The programme supports people with common conditions including musculoskeletal, mental health, and metabolic conditions, with early results indicating improved health and employment outcomes. Integrated working and local partnerships are key success factors: a multidisciplinary team nationally across DWP, DHSC and NHSE and locally across Integrated Care Boards and MCAs successfully co-design and deliver the programme as one team.

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps his Department is taking with the Department of Health and Social Care to assess how changes to the Access to Work programme’s policy, implementation and claimant interactions could improve health outcomes and prevent avoidable deterioration of health for disabled people and people with long-term health conditions.

Answered by Stephen Timms - Minister of State (Ministry of Housing Communities and Local Government) (Equalities)

Access to Work is an important programme that supports many people and reform in this area is complex. We are committed to ensuring the system remains fair, and sustainable and changes must be carefully designed to ensure they deliver real improvements and this work takes time, but it is important we get it right.

We have taken the time needed to consult widely, collaborate, and gather evidence from disabled people, employers, and representative bodies. We are continuing to refine policy options, and ministers will announce next steps when the policy, evidence, and delivery plans are fully developed.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, if she will give local and strategic authorities the guidance, resources and funding to tackle poor indoor air quality.

Answered by Emma Hardy - Minister of State (Department for Environment, Food and Rural Affairs)

Local authorities play an important role in improving air quality. Defra and DHSC are working with other departments to strengthen the evidence base and consider how housing, planning and public health can support better outcomes. Local authorities are best placed to determine local priorities and allocate available resources accordingly.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, if she will develop a national approach to indoor air quality that brings together housing, planning and public health.

Answered by Emma Hardy - Minister of State (Department for Environment, Food and Rural Affairs)

The Government recognises the importance of indoor air quality. Defra and DHSC are working with other departments to strengthen the evidence base and consider how housing, planning and public health can support better outcomes.

Question to the Department for Education:

To ask the Secretary of State for Education, what assessment she has made of the difference in financial support available to mature students undertaking (a) five-year undergraduate medicine and (b) four-year graduate-entry medicine courses, including in respect of (i) maintenance support, (ii) tuition fees, (iii) travel expenses and (iv) childcare costs.

Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)

The department works closely with the Department for Health and Social Care (DHSC) on a wide range of matters to ensure the education system supports healthcare students, including support for mature students.

In the first four years of a five-year undergraduate medical course, students can access up-front fee loans and partially means-tested loans for living costs from Student Finance England (SFE).

Additional means-tested support is available for full-time students on medical courses with one or more dependent children. This includes the Childcare Grant to help with weekly childcare costs and the Parents’ Learning Allowance for course related costs. Full-time medical students undertaking a clinical placement in the UK may also apply for a means-tested travel grant to help with associated travel costs.

Graduates wishing to study medicine or dentistry may choose a graduate-entry course. In the first year of graduate-entry medical degree, students may be eligible for a partial tuition fee loan and a partially means-tested maintenance loan from SFE.

The government has announced that maximum loans for living costs will increase annually in line with forecast inflation. For the 2026/2027 academic year, loans increased by 2.7%.

From year 5 of an undergraduate course and from year 2 of a graduate-entry course, medical students may access the NHS Bursary. This is non-repayable and includes a contribution towards tuition fees and further grants and allowances including support for childcare and travel costs, where eligible. Students in receipt of an NHS Bursary may also apply for a reduced rate loan for living costs from SFE.

DHSC increased NHS Bursary tuition fee contributions, maintenance grants and all allowances by 2.7% for the 2026/27 academic year.

Medicine and dentistry courses will attract Priority Additional Entitlement under the new Lifelong Learning Entitlement (LLE), due to be introduced from January 2027. For the first time, students who choose medicine as a second degree under the LLE will be able to access full tuition fee and standard living costs support for the years of study not covered by the NHS bursary.

Found: (DHSC).6 Primary legislation is required to disband NHSE and reallocate its statutory

Found: Good health and wellbeing We are supporting the Department of Health and Social Care with work resulting

Found: (DHSC) and is the new qualification for those working in the adult care sector and which

Found: Gynaecologists (RCOG) Royal College of Nursing (RCN) England’s Chief Medical Officer Department of Health and Social Care

Found: govuk-table__cell">British Retail Consortium

Found: The Department of Health and Social Care will give due consideration to these standards when updating

Found: urgent medical treatment in the UK following agreement about such treatment with the Department of Health and Social Care

Found: The Department of Health and Social Care has ring-fenced £3.4bn over this Spending Review period to

Found: Medicine Madingley Road CAMBRIDGE United Kingdom CB3 0ES Wider Public Sector 10007881 Department of Health and Social Care

Found: Medicine Madingley Road CAMBRIDGE United Kingdom CB3 0ES Wider Public Sector 10007881 Department of Health and Social Care

Found: The Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) have

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: system Youth Justice Board • Carers strategy: second national action plan 2014-2016 Department of Health and Social Care

Found: The Office for Health Improvement and Disparities (OHID) within Department of Health and Social Care

Found: Partners The AI Airlock Partners comprise of the following representatives: MHRA Department of Health and Social Care

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: The Office for Health Improvement and Disparities (OHID) within Department of Health and Social Care

Found: The Office for Health Improvement and Disparities (OHID) within Department of Health and Social Care

Found: It has been developed by the Department of Health and Social Care and is intended to summarise information

Found: UKHSA is an executive agency, sponsored by the Department of Health and Social Care.

Found: The Office for Health Improvement and Disparities (OHID) within Department of Health and Social Care

Found: The Office for Health Improvement and Disparities (OHID) within Department of Health and Social Care

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: Membership The PHE Variant Technical Group includes representation from the following organisations: PHE, DHSC

Found: The Department of Health and Social Care will be issuing clinical guidance on this.

Found: new national brain cancer clinical lead to drive this work forward, appointed by the Department of Health and Social Care

Found: Notes to editors The MHRA is an executive agency of the Department of Health and Social Care.

Found: The MHRA is an executive agency of the Department of Health and Social Care.   

Found: James Frith MP Minister for Health Innovation Department of Health and Social Care

Found: The Department of Health and Social Care (DHSC) is delivering the awards through the UK Vaccine Network

Found: The Department of Health and Social Care is delivering the awards through the UK Vaccine Network, which

Found: COUNTERMEASURES DELIVERY, 10 SOUTH COLONNADE, LONDON, E14 4PU, UNITED KINGDOM 18732045 DEPARTMENT OF HEALTH AND SOCIAL CARE

Found: The MHRA is an executive agency of the Department of Health and Social Care. 

Found: The MHRA is an executive agency of the Department of Health and Social Care. 

Found: The MHRA is an executive agency of the Department of Health and Social Care. 

Found: Institute for Health and Care Research (NIHR) Health Data Research Service (HDRS) Department of Health and Social Care

Found: department, 2025-20261 1 Departments with at least five OA, IA or PIR submissions: DfT – 19, DBT – 18, DHSC

Found: Roundtable discussion on maternal health R E E G members invited Department of Health and Social Care

Found: (DHSC) to conduct a review of the risks of toxicity from chemicals in the diet of girls

Found: The Department of Health and Social Care (DHSC) and devolved health departments have an important leadership

Found: of Radiation in the Environment (COMARE), a scientific advisory committee of the Department of Health and Social Care

Found: ) (Electronic Medicines Compendium 2025); Drugs and pharmaceutical eMIT (2024) (Department of Health and Social Care

Found: Once appointed, the DHSC Director for Patient Experience will join the Board.

Found: Department of Health and Social Care.

Found: Department of Health and Social Care.

Found: ) (Electronic Medicines Compendium 2025); Drugs and pharmaceutical eMIT (2024) (Department of Health and Social Care

Found: Medicine • UK Clinical Pharmacy Association • UK Oncology Nursing Society Others • Department of Health and Social Care

Found: Department of Health and Social Care.

Found: treating HER2-low metastatic or unresectable breast cancer after chemotherapy The Department of Health and Social Care

Found: Group • UK Clinical Pharmacy Association • UK Oncology Nursing Society Others • Department of Health and Social Care

Found: Group • UK Clinical Pharmacy Association • UK Oncology Nursing Society Others • Department of Health and Social Care

Found: London: Department of Health and Social Care.

Found: prevention, intervention, and care: 2024 report of the Lancet standing Commission. 66 Department of Health and Social Care

Found: Department of Health and Social Care, Parliamentary Under-Secretary of State for Public Health and Prevention

Found: The Bill is sponsored by the Department of Health and Social Care.

Found: We would also encourage the Committee to scrutinise the steps being taken by the Department of Health and Social Care

Found: Welsh NHS Trusts; income from the Scottish Government, Northern Ireland Executive, Department of Health and Social Care

Found: claim for 2026/27 105 Home Office Immigration Health Surcharge 2026-27 50,242 Department of Health and Social Care

Found: establish a standing pharmaceutical expert advisory panel, in consultation with the Department of Health and Social Care